FR3089761B1 - Liquid composition of electronic cigarette - Google Patents

Liquid composition of electronic cigarette Download PDF

Info

Publication number
FR3089761B1
FR3089761B1 FR1872736A FR1872736A FR3089761B1 FR 3089761 B1 FR3089761 B1 FR 3089761B1 FR 1872736 A FR1872736 A FR 1872736A FR 1872736 A FR1872736 A FR 1872736A FR 3089761 B1 FR3089761 B1 FR 3089761B1
Authority
FR
France
Prior art keywords
liquid composition
electronic cigarette
optionally
nicotine
flavor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1872736A
Other languages
French (fr)
Other versions
FR3089761A1 (en
Inventor
Kévin Prian
Marion Verthier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
E Rag
Original Assignee
E Rag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E Rag filed Critical E Rag
Priority to FR1872736A priority Critical patent/FR3089761B1/en
Publication of FR3089761A1 publication Critical patent/FR3089761A1/en
Application granted granted Critical
Publication of FR3089761B1 publication Critical patent/FR3089761B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10Chemical features of tobacco products or tobacco substitutes
    • A24B15/16Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composition liquide de cigarette électronique L’invention concerne une composition liquide de cigarette électronique, qui comprend : - entre 0,01 % et 10 %, de nicotine sous forme de base libre ; - entre 0,10 % et 20 %, de sel de nicotine ; - entre 30 % et 99 %, de solvant ; - optionnellement, entre 0,01 % et 30 %, d’arôme ; - optionnellement, entre 0,01 % et 10 %, d’additif.Liquid composition for an electronic cigarette The invention relates to a liquid composition for an electronic cigarette, which comprises: - between 0.01% and 10%, nicotine in the form of the free base; - between 0.10% and 20%, of nicotine salt; - between 30% and 99%, of solvent; - optionally, between 0.01% and 30%, flavor; - optionally, between 0.01% and 10%, additive.

FR1872736A 2018-12-12 2018-12-12 Liquid composition of electronic cigarette Active FR3089761B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1872736A FR3089761B1 (en) 2018-12-12 2018-12-12 Liquid composition of electronic cigarette

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1872736A FR3089761B1 (en) 2018-12-12 2018-12-12 Liquid composition of electronic cigarette

Publications (2)

Publication Number Publication Date
FR3089761A1 FR3089761A1 (en) 2020-06-19
FR3089761B1 true FR3089761B1 (en) 2021-01-29

Family

ID=66542360

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1872736A Active FR3089761B1 (en) 2018-12-12 2018-12-12 Liquid composition of electronic cigarette

Country Status (1)

Country Link
FR (1) FR3089761B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112851636B (en) * 2021-01-20 2022-04-05 深圳市艾普生物科技有限公司 Preparation method and application of synthetic nicotine salt
CN113545510A (en) * 2021-06-17 2021-10-26 深圳市博睿生物科技有限公司 Nicotine salt, preparation method and application

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060018840A1 (en) * 2004-06-28 2006-01-26 Nektar Therapeutics Aerosolizable formulation comprising nicotine
US20120325228A1 (en) * 2011-06-23 2012-12-27 Williams Jonnie R Alkaloid composition for e-cigarette
GB2535427A (en) * 2014-11-07 2016-08-24 Nicoventures Holdings Ltd Solution

Also Published As

Publication number Publication date
FR3089761A1 (en) 2020-06-19

Similar Documents

Publication Publication Date Title
MX2020006612A (en) Compound functioning as bromodomain protein inhibitor, and composition.
PH12017502181A1 (en) Nutritional compositions containing an elevated level of inositol and uses thereof
MX2020014031A (en) Heterodimeric proteins and uses thereof.
FR3089761B1 (en) Liquid composition of electronic cigarette
CO2021001472A2 (en) Transglutaminase 2 (tg2) inhibitors
NZ763528A (en) Heterocyclic gpr119 agonist compounds
EA201900033A1 (en) TOBACCO PRODUCT WITH FLUORESCENT OR PHOSPHORESCENT SUBSTANCES
EA201992504A1 (en) MAGL INHIBITORS BASED ON PYRAZOL
WO2018081531A3 (en) Methods for human t-cell activation
MX2019000980A (en) Compounds and compositions and uses thereof.
NZ734400A (en) Amide compounds as 5-ht4 receptor agonists
MX2020008125A (en) Compositions comprising berberine.
EA202092464A1 (en) METHODS FOR PREPARING STABLE PROTEIN-BASED COMPOSITIONS
JOP20210326A1 (en) Natriuretic peptide receptor 1 antibodies and methods of use
MY190623A (en) Anti-vegf protein compositions and methods for producing the same
MX2021015154A (en) Pharmaceutical parenteral composition of dual glp1/2 agonist.
EA201891337A2 (en) PHARMACEUTICAL COMPOSITION FROM NEUROPATHIC PAIN
EP4293116A3 (en) Stable liquid fibrinogen
PH12020550804A1 (en) Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a copolyamino acid
MX2019011867A (en) Pparî³ agonist for treatment of progressive supranuclear palsy.
PE20211387A1 (en) ORGANIC COMPOUNDS
EA201991112A1 (en) COMPOSITIONS AND METHODS ASSOCIATED WITH 5-HT1F Pyridinoylpiperidine Agonists
MY196314A (en) Methods, Compositions and Uses Relating Thereto
EA201790006A1 (en) COMPOSITION OF SLIDING SOAP AND METHODS OF PRESERVING AN IMPROVED FOAMING IN WATER WITH HIGH ELECTROLYTE CONCENTRATION
MX2021006978A (en) Dodeca-4,8,11-trien-1-ol and its use as aroma chemical.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20200619

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6